Zydus Lifesciences Limited has informed the Exchange about General Updates
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences has informed the exchanges that its step-down subsidiary Ampliman 2, based in France, has been dissolved without liquidation effective January 9, 2026. Ampliman 2 was a wholly owned subsidiary of Zydus MedTech (France) S.A.S., which itself is a wholly owned step-down subsidiary of Zydus Lifesciences. All assets and liabilities of Ampliman 2 have been absorbed by Zydus MedTech (France) S.A.S. The company has stated this restructuring will have no impact on its business operations.
This is a routine internal restructuring with no operational or financial impact on Zydus Lifesciences. Shareholders are unlikely to see any material effect on the stock or business.